Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Upstream Processing01:27

Upstream Processing

Upstream processing represents a critical phase in biomanufacturing, wherein biological systems such as microorganisms, mammalian cells, or insect cells are cultivated to produce therapeutic proteins, vaccines, enzymes, or other biologically derived products. This phase encompasses all steps from the selection and genetic manipulation of the production organism to the cultivation of cells in bioreactors under tightly controlled environmental conditions.Host Selection and Genetic OptimizationThe...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Integrating AI in Medicinal Chemistry for Accelerated Drug Discovery: A Comprehensive SAR (CSAR) Optimization Strategy and Discovery of Potent ALDH3A1 Inhibitors.

Journal of medicinal chemistry·2026
Same author

High yield production of C-terminally processed KRAS4a, HRAS, and NRAS for biophysical study.

Protein expression and purification·2026
Same author

mRNA COVID-19 vaccination induces minimal IgA in saliva in the absence of prior clinical or subclinical infection.

Vaccine·2026
Same author

Disulfide tethering reveals cryptic pockets in oncogenic KRAS.

Communications chemistry·2026
Same author

Dynamic switching of apoptosis-modulating BIM heterodimers in response to BH3 mimetics in xenograft models of hematologic malignancies.

Molecular cancer therapeutics·2026
Same author

Estimating the decay of protective antibodies induced by SARS-CoV-2 mRNA vaccination and hybrid immunity.

Npj viruses·2025
Same journal

Tracking Synthetic Adhesins on Bacterial Surfaces with Immunofluorescence Microscopy.

Methods in molecular biology (Clifton, N.J.)·2026
Same journal

Post-Selection Methods for Analyzing mRNA Display Selections and Optimization of Hits.

Methods in molecular biology (Clifton, N.J.)·2026
Same journal

High-Performance Computing in Tandem Mass Spectrometry (MS/MS) Peptide Identification.

Methods in molecular biology (Clifton, N.J.)·2026
Same journal

Engineering and Adapting Disulfide-Containing Proteins to Enable Intracellular Functionality.

Methods in molecular biology (Clifton, N.J.)·2026
Same journal

AI-Driven Protein Research: From Prediction to Design.

Methods in molecular biology (Clifton, N.J.)·2026
Same journal

Methods for the In Vitro Selection of Protein and Peptide Libraries Using mRNA Display.

Methods in molecular biology (Clifton, N.J.)·2026
See all related articles

Related Experiment Video

Updated: Jun 28, 2026

Generation of Plasmid Vectors Expressing FLAG-tagged Proteins Under the Regulation of Human Elongation Factor-1α Promoter Using Gibson Assembly
10:18

Generation of Plasmid Vectors Expressing FLAG-tagged Proteins Under the Regulation of Human Elongation Factor-1α Promoter Using Gibson Assembly

Published on: February 9, 2015

Gateway cloning for protein expression.

Dominic Esposito1, Leslie A Garvey, Chacko S Chakiath

  • 1Protein Expression Laboratory, National Cancer Institute, SAIC-Frederick, Frederick, MD, USA.

Methods in Molecular Biology (Clifton, N.J.)
|November 7, 2008
PubMed
Summary
This summary is machine-generated.

Recombinational cloning, especially the Gateway system, accelerates protein expression clone generation. This overcomes bottlenecks in producing soluble, high-yield proteins, making research more efficient and cost-effective.

More Related Videos

Rapid Assembly of Multi-Gene Constructs using Modular Golden Gate Cloning
08:31

Rapid Assembly of Multi-Gene Constructs using Modular Golden Gate Cloning

Published on: February 5, 2021

A High-throughput Automated Platform for the Development of Manufacturing Cell Lines for Protein Therapeutics
07:48

A High-throughput Automated Platform for the Development of Manufacturing Cell Lines for Protein Therapeutics

Published on: September 22, 2011

Related Experiment Videos

Last Updated: Jun 28, 2026

Generation of Plasmid Vectors Expressing FLAG-tagged Proteins Under the Regulation of Human Elongation Factor-1α Promoter Using Gibson Assembly
10:18

Generation of Plasmid Vectors Expressing FLAG-tagged Proteins Under the Regulation of Human Elongation Factor-1α Promoter Using Gibson Assembly

Published on: February 9, 2015

Rapid Assembly of Multi-Gene Constructs using Modular Golden Gate Cloning
08:31

Rapid Assembly of Multi-Gene Constructs using Modular Golden Gate Cloning

Published on: February 5, 2021

A High-throughput Automated Platform for the Development of Manufacturing Cell Lines for Protein Therapeutics
07:48

A High-throughput Automated Platform for the Development of Manufacturing Cell Lines for Protein Therapeutics

Published on: September 22, 2011

Area of Science:

  • Molecular Biology
  • Protein Expression
  • Biotechnology

Background:

  • Protein production is often limited by the inefficient generation of expression clones.
  • Producing functional human proteins in heterologous systems is challenging due to poor expression, aggregation, or purification issues.
  • Traditional cloning methods are time-consuming, costly, and often require multiple steps and redesigns.

Purpose of the Study:

  • To highlight the challenges in generating functional protein expression clones.
  • To introduce recombinational cloning as a solution to these challenges.
  • To emphasize the flexibility and efficiency of the Gateway system for protein expression.

Main Methods:

  • Discusses the limitations of traditional gene cloning for protein expression.
  • Introduces recombinational cloning techniques.
  • Highlights the Gateway recombinational cloning system.

Main Results:

  • Recombinational cloning enables rapid, parallel generation of expression clones.
  • The Gateway system offers high flexibility for protein expression.
  • This approach reduces costs and time associated with protein production pipelines.

Conclusions:

  • Recombinational cloning significantly improves protein expression workflows.
  • The Gateway system provides a robust and efficient method for generating expression clones.
  • This technology facilitates both low- and high-throughput protein production.